Satya Narayan Brahma

Editor-in-chief

Satya is a hardcore Communication professional with a Out Of Box thinking attitude and a proven & Pro-Active Leader in Strategic Communication Initiatives. Strong interpersonal skills coupled with Independent leadership in fueling the growth of Organization's image building. Strong Experience in Internal & External Communications with a focus on addressing Investors Relations. Established contacts with Media, Corporate tycoons & Government Policy Makers. As a political scientist, Satya emphasises the occasional need for the methodical exercise of brute force, deceit, and so on. He is sometimes seen as the prototype of a modern empirical scientist, building generalizations from experience and historical facts, and emphasizing the uselessness of theorizing with the imagination. Satya's promotion of ambition amongst leaders while denying any higher standard meant that he encouraged risk taking, and innovation, most famously the founding of new modes and orders. Satya feels that an individual has not started living until he can rise above the narrow confines of his individualistic concerns to the broader concerns of all humanity. An individual who breaks a law that conscience tells him is unjust, and who willingly accepts the penalty of imprisonment in order to arouse the conscience of the community over its injustice, is in reality expressing the highest respect for the law. Change does not roll in on the wheels of inevitability, but comes through continuous struggle. And so we must straighten our backs and work for our freedom. A man can't ride you unless your back is bent.Darkness cannot drive out darkness; only light can do that. Hate cannot drive out hate; only love can do that. Discrimination is a hellhound that gnaws at Negroes in every waking moment of their lives to remind them that the lie of their inferiority is accepted as truth in the society dominating them. Every man must decide whether he will walk in the light of creative altruism or in the darkness of destructive selfishness. Entrepreneurs are simply those who understand that there is little difference between obstacle and opportunity and are able to turn both to their advantage. Whosoever desires constant success must change his conduct with the times. Men ought either to be indulged or utterly destroyed, for if you merely offend them they take vengeance, but if you injure them greatly they are unable to retaliate, so that the injury done to a man ought to be such that vengeance cannot be feared. Men rise from one ambition to another: first, they seek to secure themselves against attack, and then they attack others. The wish to acquire more is admittedly a very natural and common thing; and when men succeed in this they are always praised rather than condemned. But when they lack the ability to do so and yet want to acquire more at all costs, they deserve condemnation for their mistakes. There are three kinds of intelligence: one kind understands things for itself, the other appreciates what others can understand, the third understands neither for itself nor through others. This first kind is excellent, the second good, and the third kind useless.

Satya has pioneered the leadership movement for the pharmaceutical & healthcare industries in India as he has edited some of the biggest news titles in the country. He is widely seen as a powerful voice for the industry as he has been pressing for radical reforms in the sector to the various Government & Statutory bodies. To his credit, Satya has organized many national & international meets like Pharmaceutical Leadership Summit, Jai Mumbai, India Leadership Conclave, medical meets, Zero to Billion Bhubaneswar & Bangalore edition. Satya has woked with Companies like Indian express, Expomedia group, Ijm Group, Akshayapatra & Wockhardt & has made a deep imprints on those companies. Satya is armed with a Master's Degree in internal studies with a Mass Communication post graduation. He is a much sought after speaker in various national & international forums.

Prabhat Sinha

Consulting Editor
Strategic Affairs & CEO SMG

SMG initiated its business in 2002 by Prabhat Sinha with the view to connect enterprising Indian business owners globally. In just seven years, SMG has built a network among 10 million competent and trusted business owners across industries, trades and professions. A vibrant, enterprising community that acquires knowledge, technologies, skills and opportunities with the view to compete globally. SMG created unique and innovative methods that included B2B summits across 100 towns in India and 12 overseas.

Whilst SMG initiatives have helped business owners acquire knowledge from a range of global experts, several new business relationships, partnerships and trades have struck for many. Across a range of industries: automotive, apparel and fashion, art & craft, banking, food & beverages, chemicals, computer hardware, energy, health, insurance, information technology & services, finance & investments, logistics, media, oil & gas, telecommunications among others. The rapid results came in primarily because the handshake environment helped people relate better with greater levels of trust and goodwill. In contrast to online connections for business, we believe, summits and meets are efficient ways to strike stronger relations and rapport.

Abidali Dossa

Executive Editor

Abid has 12 years experience in visualising and creating interactive knowledge forums, professional b2b conferences, and training workshops for India, Malaysia and Middle East region. Knowledge forums produced by Abid has been attended by packed audiences, for a wide range of industries and job functionalities. Conferences and knowledge forums produced by me are innovative, original and constantly receive high ratings from the participating audience, with elevated interaction levels and a very strong focus on generating practical solutions for the attending participants.

As a business leader, He has successfully initiated and grown conference divisions of 3 companies in South East Asia. I was responsible for the growth of conference production division for the regional HQ, while based in Malaysia for India and Middle East managing a team of 12 producers. I have also fast tracked the growth of a specialised conference company in India to a team of 60 staff members with 25 events in a period of 18 months. His current focus is on producing innovative, knowledge sharing meets which focus on generating new thoughts, ideas and solutions.

Debasish Chakrabartty

Editorial Co-Ordinator

Debasish Chakrabartty has done his MBA and PGDBA from Orissa. He is a Confident, creative and highly qualified marketing professional with 2 years of distinguished performance in the web space and computer industries. Broad-based background encompasses exceptional work ethic and commitment to organizational objectives within highly competitive and rapidly changing marketplace. He has worked closely with Infocom Network Ltd to ensure that the products and services met market needs and were executed on time and on budget. Worked closely with trade shows to promote our company in the regional and national level. .

He has also worked with Accutech Infosystem Pvt Ltd Business Partner of Emerson Network Power. Worked as individual sales representatives to help fulfill marketing such as lead generation, and sales analysis. Supported Branch Manager by managing sales budget, demo equipment inventory, interacting with sales representatives on marketing issues.

He now works with Wockhardt Foundation as executive –Market Research helping our team with our event Management programme, Brand building, coordinate with web team to develop web site, tying other NGOs with us to work effectively for the upliftment of the poor. Apart from that he assists our CEO in various programmes such as preparing Power point Presentation for International and national conferences. Building strategy to get funding.

Rabia Jaffer

Editorial Co-Ordinator

Rabia works for Kingfisher Airlines. . Born in Mumbai, she did her schooling partly there and then moved to Dubai with her parents. She has completed her O and A level from Cambridge University in Dubai. She is a very innovative person and have tried her hands on a couple of fields like Banking, Media (Direction), Advertising and now Aviation. Since she was in school she has actively participated in a lot of extra curricular activities when it came to helping people around or trying to make a difference. As she was a part of a convent school she did get plenty of opportunities to help the orphans and the old. Even in Dubai she was a voluntary member of the Red Cross Society and Valley of Love. As she moved to India, she always wanted to get back to doing what she had been since.

Mr. Shivnath Thukral

Group President
Corporate Branding & Strategic Initiatives
ESSAR Group

Shivnath Thukral recently joined Essar as its Group President, Corporate Branding & Strategic Initiatives. In this position, Shivnath is responsible for strategically reaching out to various stake holders to appropriately position the Essar brand.

Before this, Shivnath spent 14 years in NDTV, India’s largest television news channel. In his last role, Shivnath was the Group Business Editor & Advisor Strategy with NDTV. In his time spent with NDTV, Shivnath gained a rich experience of analyzing Indian businesses, financial markets and economic affairs.

Shivnath was also the Managing Editor of NDTV Profit and instrumental in setting up of NDTV’s business channel. He is among the most trusted faces in business journalism India has produced. With more than 14 years of experience in television as a presenter and a moderator, Shivnath has built a reputation of engaging India’s top CEOs and politicians on the same platform with equal elegance.

Among Shivnath’s biggest interviews are prominent personalities like Ratan Tata, Mukesh Ambani, Anil Ambani, NR Narayanamurthy, Nandan Nilekani, Kumarmanglam Birla, Anand Mahindra, LN & Aditya Mittal, Richard Branson, Vijay Mallya, Arun Sarin, KV Kamath, P Chidambaram, Lalu Prasad Yadav, Praful Patel, Jean Claude Trichet of ECB and Dr YV Reddy of RBI.

Mr. Kewal Handa

Managing Director
Pfizer Ltd. and Wyeth Ltd.

Kewal Handa is Managing Director, Pfizer Limited, the world’s No.1 pharmaceutical company that discovers and develops break-through drugs, provides information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines, consumer products; and is a global leader in corporate responsibility. Under his leadership, the company is now aggressive in its growth plans and has launched several new products.

Kewal is a reputed industry expert who takes the lead on key issues that concern the pharmaceutical sector. As Vice President of the Organisation of Pharmaceutical Producers of India (OPPI), he has been at the forefront of the industry’s efforts to resolve issues pertaining to the pharmaceutical sector. He is also the Chairman of DPCO & Taxation Committee of OPPI. He has recently been appointed as the President of All India Management Association and is a committee member of various industry bodies in the country.

Kewal was awarded the ‘India CFO 2004 – Excellence in Finance in an MNC’ by International Market – Assessment Group and has recently won the Bharat Shiromani Award.

A qualified Management Accountant and Company Secretary, and with a Masters Degree in Commerce from Sydenham College, Mumbai, Kewal has completed the Pfizer Leadership Development Program from Harvard University, the Senior Management Development Program from IIM, Ahmedabad. He has also done a course on Marketing Strategy from Columbia Business School. Mr. Handa is also the Managing Director of Wyeth Ltd.

Mr. Tapan Ray

Director General, OPPI

Mr. Ray has over thirty years of national and international experience in the Healthcare Industry with Pharmaceuticals, Medical Diagnostics, Biotech, Neutraceutical/Cosmeceutical, Nutritional and Hospital Products business, based in India and the UK. Mr. Ray currently holds the position of Director General of the Organization of Pharmaceutical Producers of India (OPPI).

Mr. Ray has held various senior positions like:

• International Marketing Strategy Manager, Glaxo plc, U.K
• Director in the Board of Glaxo India Limited
• Non-Executive Director of Biddle Sawyer India Limited
• Managing Director of Abbott Laboratories India Limited
• Managing Director of Kopran Limited, India
• CEO and Director of Sami Labs Limited, India

Mr. Ray was also the President and Vice-President of the Organization of Pharmaceutical Producers of India (OPPI) and the Chairman of its Marketing Committee. Mr. Ray currently holds the position of:

• Chairman of the Board of Shasun Pharma Solutions Limited, Northumberland, England, United Kingdom (U.K.)
• Non Executive Director in the Board of Shasun Chemicals and Drugs Limited, India
• Member of the Council of International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland
• Member of the Advisory Board of Institute of Intellectual Property Studies, Mumbai
• Life Member of Bombay Management Association
• Member CII National Committee of IP owners (2010-11)
• Visiting Faculty in India’s Top Management Institutes and a Key note Speaker in various National and Inter-national seminars and conferences.

Mr. Ray holds a B.Sc (Honors) and a Masters Degree in Geology from the University of Calcutta and has been a National Scholar. He was trained at the Indian Institute of Management (IIM), Ahmedabad.

Mr. Ranjit Shahani

Vice Chairman & Managing Director
Novartis India Ltd.

Ranjit Shahani is President of OPPI (Organisation of Pharmaceutical Producers of India) and Country President responsible for the overall operations of the Novartis Group of Companies in India.

A Mechanical Engineer from Indian Institute of Technology, (IIT) Kanpur and MBA from Jamnalal Bajaj Institute of Management Studies, (JBIMS), Mumbai, he started his career with ICI in India in their businesses of Fibres & Speciality Chemicals. Later, he rose to the position of General Manager with ICI / ZENECA U.K., overseeing their Asia Pacific and LatAm operations for their Petrochemicals and Plastics division.

This was followed by a period as CEO at Roche Products Limited, after which he moved to Novartis in India in 1997, following the merger of Sandoz-Ciba.

Mr. Shahani was President of OPPI from 2001-2007. He is Past President of the Bombay Chamber of Commerce and Industry, President, Swiss Indian Chamber of Commerce, and was on the Council of the International Federation of Pharmaceuticals Manufacturers & Associations (IFPMA), Geneva. He is a thought leader in the Pharmaceutical Industry and has been actively involved in lobbying for a strong Product Patent law in the country and Data Protection and liberalization of the price control mechanism for Pharmaceuticals. He has also strongly canvassed for deterrent legislation against counterfeit drugs.

Dr. Krishna M. Ella

Chairman & Managing Director
Bharat Biotech International Limited

Dr. Krishna M. Ella pursued his early education in India and acquired his Postgraduate Degree in Agricultural Sciences with Distinction and Gold Medals. After working with Sandoz (I) Ltd and Bayer, he moved to the US for Higher Studies on a Rotary Foundation Scholarship.

Dr. Ella was awarded his Doctorate from the University of Wisconsin-Madison in Molecular Biology. He received the National Research Service Award from the National Institute of Health, Bethesda, Maryland and became a part of the Research faculty at the Medical University of South Carolina- Charleston.

As a scientist par international standard, well versed in the Plant/Human/Yeast systems, Dr. Ella has more than 30 scientific publications to his credit in peer reviewed academic journals. His expertise in Gene Expression Systems has been well acclaimed and demonstrated, internationally.

He is a member of various high level Commissions viz., X Five Year Plan – Biotechnology, Government of India, Co-chair, Human Resources & Innovation, National Biotech Policy, GoI (2004-05), Co-chair, High Technology Cooperation Groups (HTCG) – Indo-US Governments, National Task Force – Industrial Biotechnology, GoI and member of Confederation of Indian Industry's National Council on IPR. Chairman of Federation of Indian Chambers of Commerce and Industry (FICCI) – Biotech Committee, he is also the Advisor for many State Governments on Biotechnology.

Dr. Ella is the first recipient of the Best Entrepreneur of the Year, 2003. He founded and established Bharat Biotech International Limited in 1996 along with his wife Suchitra Ella. The Company today, is on the forefront of Indian Biotechnology engaged in R&D, manufacturing and marketing of vaccines and biotherapeutics.

Dr. Ramakanta Panda

Vice Chairman and
Cardio Vascular Thoracic Surgeon
Asian Heart Institute

Dr Panda's list of global accomplishments received another world-class attestation ... back home in India. In January 2009, Dr Panda and his AHI team successfully performed a redo bypass on the Indian Prime Minister Dr Manmohan Singh. And, in 2010, Dr Panda joined a select roster of Indians who have been awarded India's third highest civilian honour - the Padmabhushan. This is the latest chapter in a remarkable life of a modest schoolboy from Orissa who has achieved and surpassed all his childhood dreams. And from being a star student at AIIMS to a world-class cardiac surgeon, his story makes for a compelling telling. Dr Panda has words of counsel for the young minds who seek to emulate him: "Unless you believe that you can succeed, you never will. Take risks, but begin in a modest manner. Nothing prevails without common sense.”

Dr. Bansi Lal

President – R&D
Calyx

Dr. Bansi Lal joined Calyx in 2005 as President – R&D. A distinguished Scientist having work experience of 35 years in Drug Discovery & Synthesis Chemistry.

Mr. Malvinder Mohan Singh

Chairman
Fortis Healthcare.

Mr. Malvinder Mohan Singh was also appointed as the Chairman of the board of directors of PHL on 19 March 2010. Previously, he was the Chairman, Managing Director and Chief Executive Officer of Ranbaxy Laboratories Limited ("RLL") where he unlocked value in RLL's business model to focus on future growth drivers by monetising large on-going patent challenges, investing resources in high-growth emerging markets and forging strategic research alliances with large global pharmaceutical companies. Mr. Singh spearheaded the sale of approximately 64 per cent. of the equity share capital of RLL to Diachi Sankyo Company Limited. He is also the Chairman of Religare Technova Limited.

Further, as an entrepreneur, Mr. Singh has diversified business interests in financial services, insurance, healthcare and information technology. He is a director of several listed companies in India, namely, Religare Technova Limited and Oscar Investments Limited. Mr. Singh is a member of the Young Global Leaders (YGL) forum, an initiative of the World Economic Forum (WEF). He is also a member of the board of visitors at the Fuqua School of Business, Duke University, North Carolina, serves on the board of the Institut Européen d'Administration des Affaires (INSEAD) Global India Council and is a member of the Board of Governors, Indian Institute of Technology (IIT) Gandhinagar.

As a member of the Board of Trade, constituted by the Ministry of Commerce & Industry, Government of India, from 2004 to 2009, Mr. Singh advised the Government on critical policy issues relating to India's foreign trade policy, with the objective of significantly advancing India's exports. Mr. Singh is also a member of the Board of the Indian Council for Research on International Economic Relations (ICRIER). Mr. Singh graduated in Economics from St. Stephen’s College, Delhi and holds an MBA degree from the Fuqua School of Business, Duke University, U.S.A.

Kiran Majumdar Shaw

Founder Chairman
Boicon

Mr. Jagdish Saxena

Chairman & Managing Director
Elder Pharmaceutical

Mr. Jagdish Saxena, the founder of Elder, calls himself an entrepreneur by accident. The most aspiring attribute of Mr. Jagdish Saxena are his affable style and his very affectionate leanings towards his employees. In 1960 while he served the Indian Air Force, he had never imagined of establishing his own company. The turning point came when he decided to leave the defence job to join Tata Fison in the year 1964. There was no stopping from then as he had a meteoric rise in the corporate sector and rose to become the Managing Director of Walter Bushnell till the year 1988. Elder Saga Unfolds : In 1988 Mr. Jagdish Saxena was forced into entrepreneurship when the company he was working for shut down its pharma division leaving 300 personnel jobless. With the existing base of people putting together some savings and loans from banks and friends, Mr. Saxena started Elder Pharmaceuticals. The initial years were of great struggle. Elder started out with two or three products in antibiotics and other therapeutic areas.

The real turning point came when Mr.Saxena hit upon the idea of producing calcium supplements from natural sources and that is how Shelcal was born. It was a product that nobody was willing to sell and everyone said it would fail. But by the second year, with all marketing efforts it took off. It became clear that Elder were selling a treatment and not just calcium. Today the company boasts of 2,600 Elderites. The family tradition fostered in the company is a great strength that puts the organization in a very different league. Elder boasts of seven factories and is continuously expanding the manufacturing capacity through brownfield and greenfield expansions. Through its strategic international alliances are looking at launching many more brands in the chronic and niche segments. Elder’s vision is to reach Rs 1,000 crore (Rs 10 billion) by 2010.

Mr. Huzaifa Khorakiwala

Executive Director – Wockhardt Ltd
CEO – Wockhardt Foundation

Dr. Suresh Jadhav

Executive Director (QA)
Serum Institute of India Limited

Dr. Jadhav is the Executive Director of Serum Institute of India Limited, Pune, since 1992. He joined as a manager in Quality Control, in 1979. Dr. Jadhav holds a M.Pharm. from Nagpur University and a Ph.D. from the Haffkine Institute, Mumbai. Dr. Jadhav’s 34 years of technical expertise covers areas including biologicals quality control & assurance, good manufacturing practice techniques, pharmacology, standardisation of biochemical methods, inspections of laboratories, and pharmacological and toxicological screening of various drugs, toxins and venoms. He has also been appointed by WHO’s Global Programme for Vaccines and Immunization as a member of their Expert Review Committee on Animal Husbandry. He served on the Sabin Vaccine Institute Task Force on Harmonization for Vaccine Supply, 2003.

Dr. Suresh Jadhav

Executive Director (QA)
Serum Institute of India Limited

Dr. Jadhav is the Executive Director of Serum Institute of India Limited, Pune, since 1992. He joined as a manager in Quality Control, in 1979. Dr. Jadhav holds a M.Pharm. from Nagpur University and a Ph.D. from the Haffkine Institute, Mumbai. Dr. Jadhav’s 34 years of technical expertise covers areas including biologicals quality control & assurance, good manufacturing practice techniques, pharmacology, standardisation of biochemical methods, inspections of laboratories, and pharmacological and toxicological screening of various drugs, toxins and venoms. He has also been appointed by WHO’s Global Programme for Vaccines and Immunization as a member of their Expert Review Committee on Animal Husbandry. He served on the Sabin Vaccine Institute Task Force on Harmonization for Vaccine Supply, 2003.

Dr B R Jagga Shetty

Drug Controller of Karnataka